$PKTX
ProtoKinetix, Inc.

2024 Q2 Form 10-Q Financial Statement

#000107997324000714 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $51.05K $44.08K $73.66K
YoY Change -29.13% -40.16% -78.81%
% of Gross Profit
Research & Development $21.00K $36.63K $22.68K
YoY Change -34.33% 61.49% -86.09%
% of Gross Profit
Depreciation & Amortization $13.02K $11.32K $10.70K
YoY Change 12.53% 5.79% 1326.67%
% of Gross Profit
Operating Expenses $85.08K $92.03K $107.0K
YoY Change -26.39% -14.02% -79.07%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$85.08K -$92.03K -$107.0K
YoY Change -26.39% -14.02% -79.07%
Income Tax
% Of Pretax Income
Net Earnings -$85.08K -$92.03K -$107.0K
YoY Change -26.39% -14.02% -79.07%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01 -$0.01
Diluted Earnings Per Share $0.00 -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 352.9M shares 346.7M shares 325.5M shares
Diluted Shares Outstanding 354.0M shares 333.1M shares 325.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.200K $2.840K $6.940K
YoY Change -88.21% -59.08% -88.21%
Cash & Equivalents $2.200K $2.836K $6.942K
Short-Term Investments
Other Short-Term Assets $1.050K $1.050K $1.050K
YoY Change 0.0% 0.0% 0.0%
Inventory
Prepaid Expenses $1.050K $1.050K $1.050K
Receivables
Other Receivables
Total Short-Term Assets $3.250K $3.886K $7.992K
YoY Change -83.51% -51.38% -86.66%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $470.3K $457.5K $439.3K
YoY Change 5.14% 4.14% 19.54%
TOTAL ASSETS
Total Short-Term Assets $3.250K $3.886K $7.992K
Total Long-Term Assets $470.3K $457.5K $439.3K
Total Assets $473.5K $461.4K $447.3K
YoY Change 1.4% 3.15% 4.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $58.77K $67.57K $53.00K
YoY Change 343.19% 27.49% 657.14%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.77K $67.57K $53.00K
YoY Change 343.19% 27.49% 657.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $58.77K $67.57K $53.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $58.77K $67.57K $53.00K
YoY Change 343.21% 27.49% 657.14%
SHAREHOLDERS EQUITY
Retained Earnings -$48.04M -$47.96M -$47.56M
YoY Change 0.78% 0.84%
Common Stock $1.930K $1.874K $1.747K
YoY Change 7.52% 7.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $414.8K $393.8K $394.3K
YoY Change
Total Liabilities & Shareholders Equity $473.5K $461.4K $447.3K
YoY Change 1.4% 3.15% 4.65%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$85.08K -$92.03K -$107.0K
YoY Change -26.39% -14.02% -79.07%
Depreciation, Depletion And Amortization $13.02K $11.32K $10.70K
YoY Change 12.53% 5.79% 1326.67%
Cash From Operating Activities -$80.85K -$57.84K -$84.87K
YoY Change -43.76% -31.85% -74.77%
INVESTING ACTIVITIES
Capital Expenditures $25.78K $9.740K $13.74K
YoY Change 32.0% -29.11% -346.24%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$25.78K -$9.736K -$13.74K
YoY Change 32.0% -29.16% 146.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $80.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 106.0K $50.00K $80.00K
YoY Change -39.43% -37.5% -76.69%
NET CHANGE
Cash From Operating Activities -80.85K -$57.84K -$84.87K
Cash From Investing Activities -25.78K -$9.736K -$13.74K
Cash From Financing Activities 106.0K $50.00K $80.00K
Net Change In Cash -630.0 -$17.57K -$18.61K
YoY Change -105.38% -5.57% -1520.46%
FREE CASH FLOW
Cash From Operating Activities -$80.85K -$57.84K -$84.87K
Capital Expenditures $25.78K $9.740K $13.74K
Free Cash Flow -$106.6K -$67.58K -$98.61K
YoY Change -34.7% -31.47% -70.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-32917
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
PROTOKINETIX, INCORPORATED
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3355026
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
109 W Main St.
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dalton
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44618
CY2024Q1 dei City Area Code
CityAreaCode
740
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
434-5041
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
352880152 shares
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2836 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
20408 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3886 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
21458 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
457518 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
459099 usd
CY2024Q1 us-gaap Assets
Assets
461404 usd
CY2023Q4 us-gaap Assets
Assets
480557 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
67569 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44696 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
67569 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44696 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
350380152 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
350380152 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1874 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1850 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48347945 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48297969 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47955984 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47863958 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
393835 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
435861 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
461404 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
480557 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11317 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10703 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14125 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32763 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
29959 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
40893 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36625 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22679 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
92026 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
107038 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-92026 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-107038 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
333102754 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
333102754 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
325457929 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
325457929 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
435861 usd
CY2024Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
50000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-92026 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
393835 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
421340 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
80000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-107038 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
394302 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-92026 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-107038 usd
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
11317 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
10703 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
22873 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11470 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57836 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-84865 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9736 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
13743 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9736 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13743 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
80000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
80000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17572 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-18608 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20408 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25550 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2836 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6942 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2015 PKTX Payment To Acquire Intangible Assets
PaymentToAcquireIntangibleAssets
30000 usd
CY2015Q4 PKTX Additional Patent Applications
AdditionalPatentApplications
10000 usd
CY2015 PKTX Warrant Issued
WarrantIssued
6000000 shares
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
25000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zZANhZmHqLO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline"><span id="xdx_863_zVxPqy2s0zO3">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2024Q1 us-gaap Dividends Receivable
DividendsReceivable
0 usd
CY2023Q4 us-gaap Dividends Receivable
DividendsReceivable
0 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
514220 usd
CY2023 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
71088 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
585308 usd
CY2024Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
9736 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
595044 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
77950 usd
CY2023 PKTX Amortization
Amortization
48259 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
126209 usd
CY2024Q1 PKTX Amortization
Amortization
11317 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
137526 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
459099 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
457518 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11317 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10703 usd
CY2015Q4 PKTX Additional Patent Applications
AdditionalPatentApplications
10000 usd
CY2015 PKTX Warrant Issued
WarrantIssued
6000000 shares
CY2024Q1 PKTX Payments Related To Intangible Assets
PaymentsRelatedToIntangibleAssets
9736 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
94290000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94290000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 PKTX Due To Related Parties Currents
DueToRelatedPartiesCurrents
2500 usd
CY2023Q4 PKTX Due To Related Parties Currents
DueToRelatedPartiesCurrents
0 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-000714-index-headers.html Edgar Link pending
0001079973-24-000714-index.html Edgar Link pending
0001079973-24-000714.txt Edgar Link pending
0001079973-24-000714-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pktx-20240331.xsd Edgar Link pending
pktx_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
pktx-20240331_def.xml Edgar Link unprocessable
pktx-20240331_lab.xml Edgar Link unprocessable
pktx-20240331_pre.xml Edgar Link unprocessable
pktx_10q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pktx-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable